Lee Ainslie - Maverick Capital
Holding/activity history for  Collegium Pharmaceutical Inc. (COLL)
Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
2024   Q2 | 39,596 | 0.02 | Add 346.25% | 0.02 | $32.20 |
2024   Q1 | 8,873 | 0.01 | Buy | 0.01 | $38.77 |
2023   Q3 | 0 | 0 | Sell 100.00% | 0.00 | |
2023   Q2 | 10,401 | 0.00 | Reduce 7.92% | 0.00 | $21.54 |
2023   Q1 | 11,296 | 0.01 | Add 5.17% | 0.00 | $23.99 |
2022   Q4 | 10,741 | 0.01 | Reduce 27.09% | 0.00 | $23.18 |
2022   Q3 | 14,732 | 0.01 | Buy | 0.01 | $16.02 |
2021   Q3 | 0 | 0 | Sell 100.00% | 0.01 | |
2021   Q2 | 33,751 | 0.01 | Buy | 0.01 | $23.64 |
2021   Q1 | 0 | 0 | Sell 100.00% | 0.00 | |
2020   Q4 | 6,926 | 0.00 | Buy | 0.00 | $20.07 |
2019   Q2 | 0 | 0 | Sell 100.00% | 0.08 | |
2019   Q1 | 395,080 | 0.08 | Buy | 0.08 | $15.14 |
2018   Q4 | 0 | 0 | Sell 100.00% | 0.08 | |
2018   Q3 | 421,993 | 0.08 | Reduce 0.61% | 0.00 | $14.74 |
2018   Q2 | 424,590 | 0.12 | Buy | 0.12 | $23.85 |